Friday, December 12, 2008 4:48:54 AM
http://www.shionogi.co.jp/ir_en/news/detail/e_081212.pdf
1. The price is per tablet (good) which is 676.4 yen per tablet (about 7.5 USD). At the upper dose (which is lower then what it would be in the high dose of capacity) that would be 9 tablets a day which works out to about 25K per year (for a fully compliant patient).
Dan Welch had said he expected the price to be significantly lower then what it might be in the US. I don't understand why that would be the case but if the pricing is the same on a mg basis in the US (at 800mg TID) price would be around 33K. So if Dan is right on pricing we could be looking at something in the 50k+ range? I had thought 30k +/-. Of course it will depend on how good our data is.
2. There is a post marketing surveillance.
3. The mention of fibrosis inhibiting effect is quite interesting. The drug has been studied considerably in (small) studies in numerous other fibrotic indications (see #msg-24788957 for a partial list) and I wonder if there will be some off-label use.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM